Novavax, Inc.

About Novavax, Inc.

Novavax is a biotechnology company focused on developing and commercializing next-generation vaccines for serious infectious diseases. They utilize a proprietary recombinant nanoparticle vaccine technology platform. This platform enables the rapid design, development, and manufacturing of vaccines that mimic the structure of viruses, eliciting a strong immune response. Their pipeline includes vaccines for influenza, respiratory syncytial virus (RSV), and other critical global health threats. Novavax aims to address unmet medical needs by providing innovative and effective vaccine solutions to prevent illness and protect public health worldwide. They are committed to scientific excellence and advancing vaccine technology.